PL3019516T3 - Objaśnienie optymalizacji wprowadzania w chromatografii jonowymiennej - Google Patents
Objaśnienie optymalizacji wprowadzania w chromatografii jonowymiennejInfo
- Publication number
- PL3019516T3 PL3019516T3 PL14745049T PL14745049T PL3019516T3 PL 3019516 T3 PL3019516 T3 PL 3019516T3 PL 14745049 T PL14745049 T PL 14745049T PL 14745049 T PL14745049 T PL 14745049T PL 3019516 T3 PL3019516 T3 PL 3019516T3
- Authority
- PL
- Poland
- Prior art keywords
- elucidation
- ion exchange
- exchange chromatography
- input optimization
- chromatography input
- Prior art date
Links
- 238000004255 ion exchange chromatography Methods 0.000 title 1
- 238000005457 optimization Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8658—Optimising operation parameters
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
- B01D15/361—Ion-exchange
- B01D15/362—Cation-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
- B01D15/361—Ion-exchange
- B01D15/363—Anion-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3847—Multimodal interactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/96—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation using ion-exchange
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Confectionery (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361845890P | 2013-07-12 | 2013-07-12 | |
| EP14745049.8A EP3019516B1 (en) | 2013-07-12 | 2014-07-11 | Elucidation of ion exchange chromatography input optimization |
| PCT/US2014/046338 WO2015006686A1 (en) | 2013-07-12 | 2014-07-11 | Elucidation of ion exchange chromatography input optimization |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3019516T3 true PL3019516T3 (pl) | 2019-04-30 |
Family
ID=51257626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14745049T PL3019516T3 (pl) | 2013-07-12 | 2014-07-11 | Objaśnienie optymalizacji wprowadzania w chromatografii jonowymiennej |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US10274466B2 (enExample) |
| EP (2) | EP3536699A1 (enExample) |
| JP (2) | JP6462681B2 (enExample) |
| KR (1) | KR102251127B1 (enExample) |
| CN (1) | CN105377873B (enExample) |
| AU (1) | AU2014287044B2 (enExample) |
| BR (1) | BR112016000231A8 (enExample) |
| CA (1) | CA2918052A1 (enExample) |
| ES (1) | ES2705700T3 (enExample) |
| HR (1) | HRP20190071T1 (enExample) |
| IL (1) | IL243305B (enExample) |
| MX (1) | MX368107B (enExample) |
| PL (1) | PL3019516T3 (enExample) |
| RU (1) | RU2016104542A (enExample) |
| SG (1) | SG11201600221YA (enExample) |
| SI (1) | SI3019516T1 (enExample) |
| TR (1) | TR201818966T4 (enExample) |
| WO (1) | WO2015006686A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2705700T3 (es) | 2013-07-12 | 2019-03-26 | Hoffmann La Roche | Elucidación de la optimización de entrada en cromatografía de intercambio iónico |
| CN107110835B (zh) | 2014-11-12 | 2019-07-26 | 通用电气健康护理生物科学股份公司 | 用于确定实验参数对液相色谱协议的影响的方法和系统 |
| GB2539420B (en) * | 2015-06-16 | 2021-01-13 | Cytiva Sweden Ab | Determination of chromatography conditions |
| BR112020019882A2 (pt) * | 2018-04-02 | 2021-01-05 | Amgen Inc. | Composições de erenumabe e seus usos |
| JP2021530247A (ja) * | 2018-07-05 | 2021-11-11 | オベーション ダイアグノスティクス エルエルシー | 癌の診断のためのＢＣｌ−２抗体とイムノアッセイ |
| KR20200080748A (ko) * | 2018-12-27 | 2020-07-07 | 주식회사 폴루스 | 음이온 교환 크로마토그래피를 이용한 인슐린 전구체의 정제방법 |
| WO2024261724A1 (en) * | 2023-06-23 | 2024-12-26 | Lupin Limited | Ion-exchange chromatography for separation and analysis of charge variants |
Family Cites Families (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4666855A (en) * | 1985-07-31 | 1987-05-19 | Massachusetts Institute Of Technology | Rapid method for determining the isoelectric point for amphoteric molecules |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US5567610A (en) | 1986-09-04 | 1996-10-22 | Bioinvent International Ab | Method of producing human monoclonal antibodies and kit therefor |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| ES2037273T3 (es) | 1987-04-11 | 1993-06-16 | Ciba-Geigy Ag | Proceso de focalizacion isoelectrica y medios para llevar a cabo dicho proceso. |
| DE3850542T2 (de) | 1987-09-23 | 1994-11-24 | Bristol Myers Squibb Co | Antikörper-Heterokonjugate zur Töting von HIV-infizierten Zellen. |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| ATE144793T1 (de) | 1989-06-29 | 1996-11-15 | Medarex Inc | Bispezifische reagenzien für die aids-therapie |
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| US5229275A (en) | 1990-04-26 | 1993-07-20 | Akzo N.V. | In-vitro method for producing antigen-specific human monoclonal antibodies |
| JPH06500011A (ja) | 1990-06-29 | 1994-01-06 | ラージ スケール バイオロジー コーポレイション | 形質転換された微生物によるメラニンの製造 |
| US5571894A (en) | 1991-02-05 | 1996-11-05 | Ciba-Geigy Corporation | Recombinant antibodies specific for a growth factor receptor |
| WO1992020373A1 (en) | 1991-05-14 | 1992-11-26 | Repligen Corporation | Heteroconjugate antibodies for treatment of hiv infection |
| EP0590058B1 (en) | 1991-06-14 | 2003-11-26 | Genentech, Inc. | HUMANIZED Heregulin ANTIBODy |
| MX9204374A (es) | 1991-07-25 | 1993-03-01 | Idec Pharma Corp | Anticuerpo recombinante y metodo para su produccion. |
| WO1993006217A1 (en) | 1991-09-19 | 1993-04-01 | Genentech, Inc. | EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab')2 ANTIBODIES |
| US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
| FI941572L (fi) | 1991-10-07 | 1994-05-27 | Oncologix Inc | Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| AU3178993A (en) | 1991-11-25 | 1993-06-28 | Enzon, Inc. | Multivalent antigen-binding proteins |
| ATE419355T1 (de) | 1992-02-06 | 2009-01-15 | Novartis Vaccines & Diagnostic | Marker für krebs und biosynthetisches bindeprotein dafür |
| EP0626012B1 (en) | 1992-02-11 | 2003-07-09 | Cell Genesys, Inc. | Homogenotization of gene-targeting events |
| US5573905A (en) | 1992-03-30 | 1996-11-12 | The Scripps Research Institute | Encoded combinatorial chemical libraries |
| ATE149570T1 (de) | 1992-08-17 | 1997-03-15 | Genentech Inc | Bispezifische immunoadhesine |
| ES2091684T3 (es) | 1992-11-13 | 1996-11-01 | Idec Pharma Corp | Aplicacion terapeutica de anticuerpos quimericos y radiomarcados contra el antigeno de diferenciacion restringida de los linfocitos b humanos para el tratamiento del linfoma de las celulas b. |
| US5534615A (en) | 1994-04-25 | 1996-07-09 | Genentech, Inc. | Cardiac hypertrophy factor and uses therefor |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| US5712374A (en) | 1995-06-07 | 1998-01-27 | American Cyanamid Company | Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates |
| ATE321066T1 (de) | 1998-05-06 | 2006-04-15 | Genentech Inc | Anti-her2 antikörperzusammensetzung |
| SE9803838D0 (sv) * | 1998-11-09 | 1998-11-09 | Knut Irgum | A chromatography method and a column material useful in said method |
| IL127127A0 (en) | 1998-11-18 | 1999-09-22 | Peptor Ltd | Small functional units of antibody heavy chain variable regions |
| US6451987B1 (en) * | 1999-03-15 | 2002-09-17 | Novo Nordisk A/S | Ion exchange chromatography of proteins and peptides |
| DE60017888T2 (de) | 1999-04-05 | 2006-01-19 | Emisphere Technologies, Inc. | Dinatrium-salze, monohydrate und ethanol-solvate |
| US8372954B2 (en) | 2000-12-22 | 2013-02-12 | National Research Council Of Canada | Phage display libraries of human VH fragments |
| JP2005289809A (ja) | 2001-10-24 | 2005-10-20 | Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) | 突然変異重鎖抗体 |
| AU2003265994B2 (en) | 2002-09-11 | 2010-04-01 | Genentech, Inc. | Protein purification |
| WO2004103519A2 (en) | 2003-05-16 | 2004-12-02 | Cryobiophysica, Inc. | External gradient chromatofocusing |
| DK1639011T3 (da) | 2003-06-30 | 2009-02-16 | Domantis Ltd | Pegylerede enkelt-domæne antistoffer (dAb) |
| US7906630B2 (en) | 2004-04-27 | 2011-03-15 | PerkinElmer Heath Sciences, Inc. | Method for identifying peptides in a biological sample |
| EP1756852B1 (en) | 2004-05-20 | 2014-04-30 | Waters Technologies Corporation | Method and apparatus for identifying proteins in mixtures |
| CA2583081A1 (en) | 2004-06-16 | 2006-01-19 | Bio-Rad Laboratories, Inc. | Multichemistry fractionation |
| WO2006031370A2 (en) | 2004-08-19 | 2006-03-23 | Genentech, Inc. | Polypeptide variants with altered effector function |
| WO2006024497A1 (en) * | 2004-08-30 | 2006-03-09 | Lonza Biologics Plc. | Affinity- plus ion exchange- chromatography for purifying antibodies |
| ES2579805T3 (es) | 2004-09-23 | 2016-08-16 | Genentech, Inc. | Anticuerpos y conjugados modificados por ingeniería genética con cisteína |
| JP2006087394A (ja) * | 2004-09-27 | 2006-04-06 | Wako Pure Chem Ind Ltd | 核酸抽出方法および核酸抽出キット |
| GB0613753D0 (en) | 2006-07-11 | 2006-08-23 | Norwegian Radium Hospital Res | Method |
| JP2010089001A (ja) * | 2008-10-07 | 2010-04-22 | Japan Organo Co Ltd | クロマト分離方法 |
| CA2754528A1 (en) | 2009-03-06 | 2010-09-10 | Genetech, Inc. | Antibody formulation |
| WO2011009623A1 (en) * | 2009-07-24 | 2011-01-27 | F. Hoffmann-La Roche Ag | Optimizing the production of antibodies |
| CA2772653C (en) * | 2009-09-01 | 2019-06-25 | Genentech, Inc. | Enhanced protein purification through a modified protein a elution |
| US9278297B2 (en) * | 2010-07-09 | 2016-03-08 | Ge Healthcare Bio-Sciences Ab | Method for ion-exchange chromatography and media used thereof |
| WO2012102104A1 (ja) | 2011-01-24 | 2012-08-02 | シャープ株式会社 | 露光装置、液晶表示装置及びその製造方法 |
| JP2014510734A (ja) | 2011-03-31 | 2014-05-01 | アポテックス テクノロジーズ インコーポレイテッド | Ｄ−ガンマ−グルタミル−ｄ−トリプトファンおよびｄ−ガンマ−グルタミル−ｌ−トリプトファンのプロドラッグ |
| WO2014078729A1 (en) | 2012-11-15 | 2014-05-22 | Genentech, Inc. | IONIC STRENGTH-MEDIATED pH GRADIENT ION EXCHANGE CHROMATOGRAPHY |
| ES2705700T3 (es) | 2013-07-12 | 2019-03-26 | Hoffmann La Roche | Elucidación de la optimización de entrada en cromatografía de intercambio iónico |
-
2014
- 2014-07-11 ES ES14745049T patent/ES2705700T3/es active Active
- 2014-07-11 PL PL14745049T patent/PL3019516T3/pl unknown
- 2014-07-11 CN CN201480039460.3A patent/CN105377873B/zh active Active
- 2014-07-11 AU AU2014287044A patent/AU2014287044B2/en active Active
- 2014-07-11 WO PCT/US2014/046338 patent/WO2015006686A1/en not_active Ceased
- 2014-07-11 BR BR112016000231A patent/BR112016000231A8/pt active Search and Examination
- 2014-07-11 KR KR1020167003178A patent/KR102251127B1/ko active Active
- 2014-07-11 HR HRP20190071TT patent/HRP20190071T1/hr unknown
- 2014-07-11 SG SG11201600221YA patent/SG11201600221YA/en unknown
- 2014-07-11 EP EP18204792.8A patent/EP3536699A1/en not_active Withdrawn
- 2014-07-11 SI SI201431039T patent/SI3019516T1/sl unknown
- 2014-07-11 CA CA2918052A patent/CA2918052A1/en not_active Abandoned
- 2014-07-11 TR TR2018/18966T patent/TR201818966T4/tr unknown
- 2014-07-11 JP JP2016525805A patent/JP6462681B2/ja active Active
- 2014-07-11 EP EP14745049.8A patent/EP3019516B1/en active Active
- 2014-07-11 MX MX2016000181A patent/MX368107B/es active IP Right Grant
- 2014-07-11 RU RU2016104542A patent/RU2016104542A/ru not_active Application Discontinuation
- 2014-07-11 US US14/904,422 patent/US10274466B2/en active Active
-
2015
- 2015-12-23 IL IL243305A patent/IL243305B/en active IP Right Grant
-
2018
- 2018-12-26 JP JP2018242206A patent/JP2019090818A/ja active Pending
-
2019
- 2019-03-12 US US16/351,372 patent/US10921297B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20160161455A1 (en) | 2016-06-09 |
| JP2019090818A (ja) | 2019-06-13 |
| WO2015006686A8 (en) | 2018-10-04 |
| MX368107B (es) | 2019-09-18 |
| EP3019516A1 (en) | 2016-05-18 |
| HRP20190071T1 (hr) | 2019-02-22 |
| WO2015006686A1 (en) | 2015-01-15 |
| HK1222183A1 (zh) | 2017-06-23 |
| US10274466B2 (en) | 2019-04-30 |
| RU2016104542A (ru) | 2017-08-17 |
| EP3536699A1 (en) | 2019-09-11 |
| CN105377873B (zh) | 2021-03-30 |
| IL243305A0 (en) | 2016-03-31 |
| KR102251127B1 (ko) | 2021-05-11 |
| SG11201600221YA (en) | 2016-02-26 |
| MX2016000181A (es) | 2016-03-09 |
| CA2918052A1 (en) | 2015-01-15 |
| KR20160030251A (ko) | 2016-03-16 |
| ES2705700T3 (es) | 2019-03-26 |
| EP3019516B1 (en) | 2018-11-14 |
| BR112016000231A8 (pt) | 2019-12-31 |
| AU2014287044B2 (en) | 2020-02-06 |
| CN105377873A (zh) | 2016-03-02 |
| TR201818966T4 (tr) | 2019-01-21 |
| IL243305B (en) | 2019-09-26 |
| SI3019516T1 (sl) | 2019-02-28 |
| JP6462681B2 (ja) | 2019-01-30 |
| US10921297B2 (en) | 2021-02-16 |
| JP2016529489A (ja) | 2016-09-23 |
| AU2014287044A1 (en) | 2016-02-11 |
| US20190310234A1 (en) | 2019-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL244320B (en) | Methods for implementing specific access control | |
| EP2983804A4 (en) | Ion exchange purification of mrna | |
| GB2540483B (en) | Improved lenses | |
| EP2901307A4 (en) | SYSTEM FOR TRACKING BASKETBALL DICES | |
| GB201301764D0 (en) | Actuation of fluid-filled lenses | |
| GB2522503B (en) | Ion modification | |
| GB201317467D0 (en) | Magnetic glasses | |
| IL243305A0 (en) | Elucidation of Input Optimization of Ion-Transfer Chromatography | |
| IL243414A0 (en) | Affinity chromatography matrix | |
| DK3050055T3 (da) | Gengivelse af flerkanalsaudio ved anvendelse af interpolerede matricer | |
| GB2530454B (en) | Optimization of instruction groups across group boundaries | |
| EP3015449A4 (en) | (meth)acrylate production system | |
| EP2969754A4 (en) | DESIGN ENHANCER SYSTEM | |
| GB2517670B (en) | Ion modification | |
| GB2508683B (en) | Program execution optimization for multi-stage manycore processors | |
| GB201301859D0 (en) | Regeneration of an ion exchange column | |
| EP3095483A4 (en) | Radiotherapy spacer | |
| GB2509808B (en) | Improved lenses | |
| GB2522739B (en) | Charge-stripping of multiply-charged ions | |
| TWM475581U (en) | Analysis system of behavior | |
| SG10201403600SA (en) | Chromatography column | |
| FI20135404L (fi) | Prosessin optimointi | |
| GB2518518B (en) | Spacer | |
| AU4911P (en) | LMV200 Lomandra hystrix | |
| GB201319952D0 (en) | Methods of isolating ions |